NEURODEX INC
Arlington, MA · Founded 2018 · CIK 0001801963 · Medtech · Private
Blood test for early detection of Alzheimer's disease based on immune purification of neuronal-derived exosomes from plasma
neurodex.co →- Grants
- $5.3M
- 6 awards
- Sector median: 1
- Raised
- $1.4M
- 3 Form D · May 2023
- 41 months since last filing
- Contracts
- $49K
- 2 awards · Health and Human S
- #574 of 4531 in medtech
- Patents
- 4
- 0 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Neurodex INC:1324958 [19-011903] | $24,500 | |
| Federal grant | Department of Health and Human Services · Phase I · Presymptomatic Diagnostic Tools for Alzheimers Disease by Blood Neuron Derived Exosome Analysis | $212,300 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Federal contract | Department of Health and Human Services · Isolate And Then Quantitatively Characterize The Cargo Of Brain-derived Exosomes From Plasma Samples Obtained From A Clinical Trial Of A Nia, NIH Drug Developed To Slow The Progression Of Alzheimer's Disease. | $24,750 | |
| Private capital raised | Form D · SEC | $799,989 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia | $449,999 | |
| Private capital raised | Form D · SEC | $60,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia | $1,009,625 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia | $942,163 | |
| Federal grant | Department of Health and Human Services · Phase II · Blood-based Biomarker for Characterizing Progression and Therapeutic Response in Amyotrophic Lateral Sclerosis | $2,147,016 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia | $518,202 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 571 | MR3 Health, Inc. | $50K | $1.1M |
| 572 | SHIFT LABS, INC. | $50K | — |
| 573 | BB MEDICAL SURGICAL, INC. | $50K | — |
| 574 | NEURODEX INC | $49K | $1.4M |
| 575 | ACESO PLASMA LLC | $49K | — |
| 576 | BACTERIOSCAN, INC. | $48K | $3.8M |
| 577 | Truvian Sciences | $48K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Oded BiranDirector · Executive Officer
- Erez EitanDirector · Executive Officer
- Gary MagnantDirector
- Raphael NirDirector
Patents
- Improved Exosome Profiling For Therapy And Diagnosisapplication
- Serological Assays For Parkinson's Diseaseapplication
- Diagnostic Assays Employing Neuron-derived Exosomesapplication
- Use Of Brain-derived Exosomes In Neurodegenerative Diseasesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.